AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Johnson & Johnson Trading Volume Drops 25% Despite Stock Price Gains and CAR T Therapy Breakthrough
Generated by AI AgentAinvest Volume Radar
Wednesday, Jun 25, 2025 8:01 pm ET1min read
On June 25, 2025,
(JNJ) experienced a trading volume of $1.089 billion, marking a 24.99% decrease from the previous day. The stock price of rose by 0.06%, marking the third consecutive day of gains, with a cumulative increase of 1.66% over the past three days.Johnson & Johnson's CAR T therapy has shown promising results in treating relapsed or refractory large B-cell lymphoma (LBCL). On June 13, the company announced that patients in this category demonstrated strong response rates to its dual-targeting CAR T therapy, achieving an 80% complete response rate in early lymphoma studies. This breakthrough underscores the potential of Johnson & Johnson's innovative treatments in addressing challenging medical conditions.
In a separate development, Johnson & Johnson has completed its acquisition of Intra-Cellular Therapies, which will now operate as a business unit within the company. This strategic move is expected to enhance Johnson & Johnson's capabilities in developing and delivering advanced therapeutic solutions.
Ainvest Volume Radar
Hunt down the stocks with explosive trading volume.
Latest Articles
Kraft Heinz Slides 1.02% as Stock Ranks 486th in Daily Trading Volume Amid Institutional Splits Earnings Woes and Dividend Strain Weigh on Investor Confidence
Dec.05 2025
AVAV's 3.15% Slide Amid 21% Volume Drop, 475th Rank Signal Earnings Optimism Fizzles
Dec.05 2025
Align Technology Extends Three-Day Rally with 0.24 Gain Ranks 452nd in $250M Turnover as Dental Sector Outperforms Peers
Dec.05 2025
PPG's 0.36% Rise Outpaces 448th-Ranked Volume as Analysts Boost Aerospace Growth Outlook
Dec.05 2025
Akamai's FedRAMP Certification Drives 31.33% Volume Surge to 445th Rank, but Stock Dips 3.59% on Investor Caution
Dec.05 2025
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet